Histamine Intolerance

Immundiagnostik AG

Histamine elimination ratio (HERO)

As a new instrument for the laboratory diagnostic clarification of DAO inhibition, we offer the determination of the histamine elimination ratio (HERO).

learn more
Leaky Gut

Immundiagnostik AG

Leaky Gut - Part 3

Learn more about the diagnostic possibilities of the immunological barrier function in the context of leaky gut.

learn more

Our goal is the development and production of diagnostics

We specialise in the development and production of innovative parameters and detection methods for laboratory diagnostics and medical research.
Our focus is the development of immunological detection methods for unoccupied niches.

Our development focuses on

  • Risk identification of diseases
  • Differential diagnostics
  • Therapy monitoring

Our products include

  • Immunoassays (ELISA, EIA)
  • LC-MS/MS and HPLC applications
  • Molecularbiological tests (PCR)
  • Photometric tests

Our programme is completed by

  • Poly- and monoclonal antibodies
  • Research reagents
  • Contract analytics
  • Proficiency testing

News from Immundiagnostik

Events

National and international trade fairs & congresses

We are on site for you. Visit us at our booth at the following trade fairs and congresses. MedLab …
Products

Histamine elimination ratio (HERO) ELISA

As a new instrument for the laboratory diagnostic clarification of DAO inhibition, we offer the …
Products

Diagnostic possibilities of the immunological barrier function

In our second blog post of the series, we reported on the diagnostic possibilities of the …
Products

Diagnostic possibilities of the epithelial barrier function

In our first Blog Post (Part 1/3) of the series, we talked about the structure of the intestinal …
Products

Monkeypox virus

Monkeypox virus of the genus Orthopox in the family Poxviridae is a double-stranded DNA virus and …
Company

In Vitro Diagnostic Medical Device Regulation

As of May 26, 2022, the new In Vitro Diagnostic Device Regulation (IVDR 2017/746/EU) will apply …